Ellen Tsui

Ellen Tsui

Auto-generated profile, based on publicly available information

Ellen Tsui

The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC 3050, Australia

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 May 2024 in EMBO Molecular Medicine
Verified
Journal Article
Open access
SCShene Chiou
Shene Chiou
AAAysha H Al-Ani
Aysha H Al-Ani
YPYi Pan
Yi Pan
KPKomal M Patel
Komal M Patel
IKIsabella Y Kong
Isabella Y Kong
ASAndré L Samson
André L Samson
Necroptosis is a lytic form of regulated cell death reported to contribute to inflammatory diseases of the gut, skin and lung, as well as ischemic-reperfusion injuries of the kidney, heart and brain. However, precise identification of the cells and tissues that undergo necroptotic cell death in vivo has proven challenging in the absence of robust protocols for immunohistochemical detection. Here, we provide automated immunohistochemistry protocols to detect core necroptosis regulators – Caspase-8, RIPK1, RIPK3 and MLKL – in formalin-fixed mouse and human tissues. We observed surprising heterogeneity in protein expression within tissues, whereby short-lived immune barrier cells were replete with necroptotic effectors, whereas long-lived cells lacked RIPK3 or MLKL expression. Local changes in the expression of necroptotic effectors occurred in response to insults such as inflammation, dysbiosis or immune challenge, consistent with necroptosis being dysregulated in disease contexts. These methods will facilitate the precise localisation and evaluation of necroptotic signaling in vivo.

9 October 2025 in Blood
Verified
Journal Article
Open access
RYRaymond K. H. Yip
Raymond K. H. Yip
JEJeremy Er
Jeremy Er
LQLei Qin
Lei Qin
QNQuoc Hoang Nguyen
Quoc Hoang Nguyen
AMAllan Motyer
Allan Motyer
EHEdwin D. Hawkins
Edwin D. Hawkins
The bone marrow microenvironment is intimately linked to the biology that underpins the development and progression of multiple myeloma. However, the complex cellular and molecular features that form bone marrow niches are poorly defined. Here, we used subcellular spatial transcriptomics to profile the expression of 5001 genes in human bone marrow in the context of multiple myeloma. Using this approach, we explored the plasma cell and stroma ecosystem in bone marrow trephine biopsy specimens (herein referred to as trephines) from 21 individuals, including 7 with premalignant disease and 10 with newly diagnosed multiple myeloma. Using spatial transcriptomics in conjunction with an optimized trephine biobanking methodology, we could resolve major components of the human bone marrow microenvironment and reliably characterize distinct plasma cell populations in samples from healthy, premalignant disease and active myeloma. When plasma cells were visualized in the context of location, we detected spatially restricted subpopulations of plasma cells in 5 of 10 newly diagnosed myeloma trephines. Surprisingly, the composition of hematopoietic and stromal microenvironments varied significantly between newly diagnosed myeloma trephines. Furthermore, these differences in microenvironments were also observed within trephines that had spatially restricted plasma cell subpopulations. Thus, these data are not consistent with the hypothesis that a universal bone marrow microenvironment supports the expansion of malignant plasma cells in myeloma. Instead, we propose that myeloma subpopulations form distinct microenvironments and can vary both between patients and spatial locations.

18 October 2024 in bioRxiv
Verified
Preprint
Open access
PDF file
JKJurgen Kriel
Jurgen Kriel
JMJoel J.D. Moffet
Joel J.D. Moffet
TLTianyao Lu
Tianyao Lu
OFOluwaseun E. Fatunla
Oluwaseun E. Fatunla
VNVinod K Narayana
Vinod K Narayana
SFSaskia Freytag
Saskia Freytag
Combining molecular profiling with imaging techniques has advanced the field of spatial biology, offering new insights into complex biological processes. Focusing on diffuse IDH -mutated low-grade glioma, this study presents a workflow for Spatial Multi-omics Integration, SMINT, specifically combining spatial transcriptomics and spatial metabolomics. Our workflow incorporates both existing and custom-developed computational tools to enable cell segmentation and registration of spatial coordinates from both modalities to a common coordinate framework. During our investigation of cell segmentation strategies, we found that nuclei-only segmentation, while containing only 40% of segmented cell transcripts, enables accurate cell type annotation, but does not account for multinucleated cells. Our integrative workflow including cell-morphology segmentation identified distinct cellular neighborhoods at the infiltrating edge of gliomas, which were enriched in multinucleated and oligodendrocyte-lineage tumor cells, that may drive tumor invasion into the normal cortical layers of the brain. Highlights: Alignment and integrated analysis of spatial transcriptomic and metabolomic data Nuclei-only and cell-morphology segmentations are concordant for cell annotation Spatially distinct regions are conserved in transcriptomic and metabolomic datasets Multi-omic exploration of glioma leading edge identifies novel biological features

27 August 2026 in Science
Verified
Journal Article
Closed access
JPJiyi Pang
Jiyi Pang
AAAysha H. Al-Ani
Aysha H. Al-Ani
KPKomal M. Patel
Komal M. Patel
YZYunzhuo Zhou
Yunzhuo Zhou
SYSamuel N. Young
Samuel N. Young
JMJames M. Murphy
James M. Murphy
Inflammatory bowel disease (IBD) is a chronic condition caused by altered cytokine signaling, maladaptive immunity, dysbiosis, and intestinal barrier dysfunction. Although current therapies aim to correct these imbalances to induce remission, most patients ultimately relapse, suggesting that key pathogenic mechanisms persist. Here, we identified aberrant epithelial cell death signaling as an underlying feature of IBD that arises in patients in remission and on advanced therapy. Mechanistically, nascent inflammation skewed epithelial cells into an M1-macrophage–like transcriptional state that promoted RIPK1-independent necroptotic signaling. This signaling then triggered inducible nitric oxide synthase–assisted mitochondrial apoptosis of absorptive epithelial cells and PUMA-mediated intestinal stem cell death. Thus, aberrant epithelial cell death signaling represents a hallmark of IBD that occurs early in mucosal lesion development, persists despite current therapeutic strategies, and predicts clinical relapse.

24 March 2026 in Nature Communications
Verified
Journal Article
Open access
PDF file
SMSocorro Miranda-Hernandez
Socorro Miranda-Hernandez
MKManoharan Kumar
Manoharan Kumar
AHAlec Henderson
Alec Henderson
EGErin Graham
Erin Graham
XTXiao Tan
Xiao Tan
AKAndreas Kupz
Andreas Kupz
About two billion people are latently infected with Mycobacterium tuberculosis (Mtb), which can reside in multiple organs, including the lymphatics. The risk of latent Mtb infection (LTBI) reactivation increases with immunosuppression, such as HIV coinfection, yet the immunological correlates that maintain LTBI remain largely elusive. Using a mouse model of contained lymphatic Mtb infection we dissect the drivers of containment versus reactivation. We show that immunosuppression-induced dissemination of lymphatic Mtb and ensuing progressive disease can be prevented by vaccination with BCG or recombinant BCG even in the absence of CD4+ T cells. Multi-parameter imaging, spatial transcriptomics and network analysis reveal that anti-CD4-mediated immunosuppression triggers distinct repositioning of non-CD4 immune cells at the edge of TB lesions in cervical lymph nodes. Although B cell numbers increase, they prove dispensable for Mtb containment during CD4+ T cell loss. Using immune cell-deficient mice, cell depletion and adoptive transfers, we reveal that CD8+ T cells mediate vaccination-induced prevention of Mtb dissemination in the absence of CD4+ T cells, informing LTBI management in immunocompromised individuals.

23 October 2024
Verified
Dataset
Closed access
JKJurgen Kriel
Jurgen Kriel
JMJoel J.D. Moffet
Joel J.D. Moffet
TLTianyao Lu
Tianyao Lu
OFOluwaseun E. Fatunla
Oluwaseun E. Fatunla
VNVinod K. Narayana
Vinod K. Narayana
SFSaskia Freytag
Saskia Freytag
BioStudies – one package for all the data supporting a study